Cargando…
Comparison of rapamycin and methylprednisolone for treating inflammatory muscle disease in a murine model of experimental autoimmune myositis
Idiopathic inflammatory myopathies (IIMs) are a group of autoimmune inflammatory muscle diseases. Rapamycin has been shown to ameliorate inflammation and improve muscle function in a mouse model of experimental autoimmune myositis (EAM). In the present study, the therapeutic effect of rapamycin was...
Autores principales: | Kang, Juan, Feng, Dongyun, Yang, Feng, Tian, Xiaojia, Han, Wenjuan, Jia, Hongge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291653/ https://www.ncbi.nlm.nih.gov/pubmed/32536994 http://dx.doi.org/10.3892/etm.2020.8716 |
Ejemplares similares
-
Beneficial Role of Rapamycin in Experimental Autoimmune Myositis
por: Prevel, Nicolas, et al.
Publicado: (2013) -
Correction: Beneficial Role of Rapamycin in Experimental Autoimmune Myositis
por: Prevel, Nicolas, et al.
Publicado: (2014) -
Toll-Like Receptor 4–Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model
por: Zhang, Hongya, et al.
Publicado: (2017) -
The Potential Therapeutic Effects of Agmatine, Methylprednisolone,
and Rapamycin on Experimental Spinal Cord Injury
por: Firat, Tulin, et al.
Publicado: (2021) -
Preventive Treatment with Methylprednisolone Paradoxically Exacerbates Experimental Autoimmune Encephalomyelitis
por: Wüst, Simone, et al.
Publicado: (2012)